BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28213780)

  • 1. Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities.
    Parise CA; Caggiano V
    Breast Cancer Res Treat; 2017 May; 163(1):151-158. PubMed ID: 28213780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
    Parise C; Caggiano V
    Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011).
    Sineshaw HM; Gaudet M; Ward EM; Flanders WD; Desantis C; Lin CC; Jemal A
    Breast Cancer Res Treat; 2014 Jun; 145(3):753-63. PubMed ID: 24794028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of marital status and race/ethnicity on risk of mortality for triple negative breast cancer.
    Parise C; Caggiano V
    PLoS One; 2018; 13(4):e0196134. PubMed ID: 29698415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive history, breast-feeding and risk of triple negative breast cancer: The Breast Cancer Etiology in Minorities (BEM) study.
    John EM; Hines LM; Phipps AI; Koo J; Longacre TA; Ingles SA; Baumgartner KB; Slattery ML; Wu AH
    Int J Cancer; 2018 Jun; 142(11):2273-2285. PubMed ID: 29330856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.
    Parise CA; Caggiano V
    BMC Cancer; 2013 Oct; 13():449. PubMed ID: 24083624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in clinicopatholgic characteristics and risk of mortality between the triple positive and ER+/PR+/HER2- breast cancer subtypes.
    Parise CA; Caggiano V
    Cancer Causes Control; 2019 May; 30(5):417-424. PubMed ID: 30879205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes.
    Parise CA; Caggiano V
    J Cancer Epidemiol; 2015; 2015():813456. PubMed ID: 26339244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
    Parise CA; Bauer KR; Brown MM; Caggiano V
    Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
    Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
    J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial/Ethnic Disparities in All-Cause Mortality among Patients Diagnosed with Triple-Negative Breast Cancer.
    Wang F; Zheng W; Bailey CE; Mayer IA; Pietenpol JA; Shu XO
    Cancer Res; 2021 Feb; 81(4):1163-1170. PubMed ID: 33272926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic status and incidence of breast cancer by hormone receptor subtype.
    Akinyemiju TF; Pisu M; Waterbor JW; Altekruse SF
    Springerplus; 2015; 4():508. PubMed ID: 26405628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Mortality among Asian-American Women in California: Variation according to Ethnicity and Tumor Subtype.
    Parise C; Caggiano V
    J Breast Cancer; 2016 Jun; 19(2):112-21. PubMed ID: 27382386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic predictors of delayed- versus early-stage cervical cancer in California.
    Saghari S; Ghamsary M; Marie-Mitchell A; Oda K; Morgan JW
    Ann Epidemiol; 2015 Apr; 25(4):250-5. PubMed ID: 25794765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.
    Bauer KR; Brown M; Cress RD; Parise CA; Caggiano V
    Cancer; 2007 May; 109(9):1721-8. PubMed ID: 17387718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for breast cancer subtypes among Black women undergoing screening mammography.
    Friebel-Klingner TM; Ehsan S; Conant EF; Kontos D; Domchek SM; McCarthy AM
    Breast Cancer Res Treat; 2021 Oct; 189(3):827-835. PubMed ID: 34342765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California.
    Banegas MP; Tao L; Altekruse S; Anderson WF; John EM; Clarke CA; Gomez SL
    Breast Cancer Res Treat; 2014 Apr; 144(3):625-34. PubMed ID: 24658879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
    Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
    Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home mortgage discrimination and incidence of triple-negative and Luminal A breast cancer among non-Hispanic Black and non-Hispanic White females in California, 2006-2015.
    Michaels EK; Canchola AJ; Beyer KMM; Zhou Y; Shariff-Marco S; Gomez SL
    Cancer Causes Control; 2022 May; 33(5):727-735. PubMed ID: 35113296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neighborhood and racial influences on triple negative breast cancer: evidence from Northeast Ohio.
    Eom KY; Berg KA; Joseph NE; Runner K; Tarabichi Y; Khiyami A; Perzynski AT; Sossey-Alaoui K
    Breast Cancer Res Treat; 2023 Apr; 198(2):369-381. PubMed ID: 36781520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.